After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Jazz Pharmaceuticals plc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Jazz Pharmaceuticals plc is $7.43B. A total of 0.5 million shares were traded on the day, compared to an average of 615.76K shares.
In the most recent transaction, COZADD BRUCE C sold 1,500 shares of JAZZ for 123.43 per share on Jan 02 ’25. After the transaction, the Chairman & CEO now owns 425,525 company shares. In a previous transaction on Jan 02 ’25, COZADD BRUCE C bought 1,500 shares at 123.43 per share.
Among the insiders who sold shares, COZADD BRUCE C disposed of 2,000 shares on Dec 02 ’24 at a per-share price of $121.17. This resulted in the Chairman & CEO holding 427,025 shares of JAZZ after the transaction. In another insider transaction, Carr Patricia sold 53 shares at $122.49 per share on Dec 02 ’24. Company shares held by the SVP, Chief Accounting Officer now total 6,596.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, JAZZ has a high of $134.17 and a low of $99.06.
As of this writing, JAZZ has an earnings estimate of $5.79 per share for the current quarter. EPS was calculated based on a consensus of 17.0 estimates, with a high estimate of $6.19 per share and a lower estimate of $5.03.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. JAZZ’s latest balance sheet shows that the firm has $591.45M in Cash & Short Term Investments as of fiscal 2021. There were $6.15B in debt and $809.30M in liabilities at the time. Its Book Value Per Share was $69.01, while its Total Shareholder’s Equity was $3.97B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JAZZ is Buy with a score of 4.53.
